Covax Australia

Covax Australia, established in 2020, operates within the Hospitals & Clinics and Healthcare sectors, providing a broad spectrum of innovative healthcare services across Australia. The company focuses on delivering essential solutions to both public and private entities, aiming to enhance healthcare delivery and accessibility. Its strategic establishment in 2020 positions it as a relatively new but impactful player in the Australian health landscape.

The company's operational scope includes robust workforce solutions, specializing in staffing for clinical and non-clinical roles, and high-quality in-home care services through its subsidiary, KnG Gold Care. Covax Australia also supplies critical medical equipment and manages healthcare facilities, supporting a workforce of 500 - 1,000 employees. With an annual revenue of $49.0M, the organization demonstrates significant operational scale and capacity. Meet Covax Australia's team to understand the leadership driving these comprehensive services.

Covax Australia plays a vital role in public health initiatives, notably as a major supplier of COVID-19 rapid antigen test kits and a supporter of the National Medical Stockpile. Their commitment to stringent quality and compliance standards ensures effective health needs fulfillment for the Australian community. The company's integrated approach, from staffing to equipment supply and specialized care, underscores its dedication to advancing healthcare services nationwide.